Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IFNGR1 Antikörper (AA 24-557) (FITC)

Der FITC-konjugierte Kaninchen Polyklonal anti-IFNGR1 Antikörper (ABIN8001082) detektiert spezifisch IFNGR1 in FACS. Dieser Antikörper reagiert spezifisch mit Proben aus Maus und Ratte.
Produktnummer ABIN8001082
720,50 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 8 bis 12 Werktagen

Kurzübersicht für IFNGR1 Antikörper (AA 24-557) (FITC) (ABIN8001082)

Target

Alle IFNGR1 Antikörper anzeigen
IFNGR1 (Interferon gamma Receptor 1 (IFNGR1))

Reaktivität

  • 97
  • 44
  • 21
  • 8
Maus, Ratte

Wirt

  • 94
  • 18
  • 8
  • 6
  • 3
  • 2
Kaninchen

Klonalität

  • 88
  • 42
  • 1
Polyklonal

Konjugat

  • 59
  • 14
  • 10
  • 8
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Dieser IFNGR1 Antikörper ist konjugiert mit FITC

Applikation

  • 70
  • 67
  • 39
  • 35
  • 26
  • 20
  • 9
  • 8
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS)
  • Bindungsspezifität

    • 16
    • 12
    • 11
    • 8
    • 7
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 24-557

    Verwendungszweck

    Anti-Ifngr1 Antibody FITC Conjugated

    Kreuzreaktivität (Details)

    No cross reactivity with other proteins.

    Homologie

    Human PADI3 shares 85.8%,86.5% amino acid (aa) sequence identity with mouse,rat PADI3,respectively.

    Aufreinigung

    Immunogen affinity purified.

    Immunogen

    E.coli-derived human PADI3 recombinant protein (Position: E24-R557). Human PADI3 shares 85.8% and 86.5% amino acid (aa) sequence identity with mouse and rat PADI3, respectively.

    Isotyp

    IgG
  • Applikationshinweise

    Flow Cytometry, Optimal dilutions should be determined by end users.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.

    Haltbarkeit

    12 months
  • Target

    IFNGR1 (Interferon gamma Receptor 1 (IFNGR1))

    Andere Bezeichnung

    Ifngr1

    Hintergrund

    Background: Interferon gamma receptor 1 (IFNGR1) also known as CD119 (Cluster of Differentiation 119), is a protein that in humans is encoded by the IFNGR1 gene. IFN-γ plays key roles in both the innate and adaptive immune response. IFN-γ activates the cytotoxic activity of innate immune cells, such as macrophages and NK cells. IFN-γ production by NK cells and antigen presenting cells (APCs) promotes cell-mediated adaptive immunity by inducing IFN-γ production by T lymphocytes, increasing class I and class II MHC expression, and enhancing peptide antigen presentation. Due to differences in the degree of glycosylation, there are 3 forms of IFN-γ, with approximate molecular weights of 25, 20, and 15.5 kDa by SDS-PAGE. The anti-viral activity of IFN-γ is due to its induction of PKR and other regulatory proteins. Binding of IFN-γ to the IFNGR1/IFNGR2 complex promotes dimerization of the receptor complexes to form the (IFNGR1/IFNGR2)2 -IFN-γ dimer. Binding induces a conformational change in receptor intracellular domains and signaling involves Jak1, Jak2, and Stat1. The critical role of IFN-γ in amplification of immune surveillance and function is supported by increased susceptibility to pathogen infection by IFN-γ or IFNGR knockout mice and in humans with inactivating mutations in IFNGR1 or IFNGR2. IFN-γ also appears to have a role in atherosclerosis.

    Gene Full Name: interferon gamma receptor 1

    Gen-ID

    15979

    UniProt

    P15261

    Pathways

    Interferon-gamma Pathway
Sie sind hier:
Chat with us!